0000899243-20-012163.txt : 20200506
0000899243-20-012163.hdr.sgml : 20200506
20200506190736
ACCESSION NUMBER: 0000899243-20-012163
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200504
FILED AS OF DATE: 20200506
DATE AS OF CHANGE: 20200506
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS
CENTRAL INDEX KEY: 0001413822
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37609
FILM NUMBER: 20854052
MAIL ADDRESS:
STREET 1: 333 ALLERTON AVE.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: MyoKardia, Inc.
CENTRAL INDEX KEY: 0001552451
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 455500552
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650-741-0900
MAIL ADDRESS:
STREET 1: 1000 SIERRA POINT PARKWAY
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: MyoKardia Inc
DATE OF NAME CHANGE: 20120618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-05-04
0
0001552451
MyoKardia, Inc.
MYOK
0001413822
GIANAKAKOS ANASTASIOS
C/O MYOKARDIA, INC.
1000 SIERRA POINT PARKWAY
BRISBANE
CA
94005
1
1
0
0
President and CEO
Common Stock
2020-05-04
4
S
0
1386
56.9317
D
77736
D
Common Stock
2020-05-04
4
S
0
400
58.045
D
77336
D
Common Stock
2020-05-04
4
S
0
2909
59.0979
D
74427
D
Common Stock
2020-05-04
4
S
0
305
60.152
D
74122
D
Common Stock
130407
I
By Reporting Person's Trust 2
Common Stock
300000
I
By Reporting Person's Trust 4
Common Stock
6000
I
By Reporting Person's Trust 5
Common Stock
53087
I
By Trust 1
Common Stock
53087
I
By Trust 2
Common Stock
53087
I
By Trust 3
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Represents the weighted average sale price of the shares sold ranging from $56.46 to $57.35 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the ranges reported in footnotes 2, 4, 5 and 6.
Includes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020, and excludes (a) 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020 and (b) 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020.
Represents the weighted average price of the shares sold ranging from $57.48 to $58.40 per share.
Represents the weighted average price of the shares sold ranging from $58.60 to $59.45 per share.
Represents the weighted average price of the shares sold ranging from $59.67 to $60.17 per share.
Excludes 95,540 shares previously held by The TKG Trust dated November 2, 2006 which were contributed to the Reporting Person directly on May 1, 2020.
Includes 300,000 shares previously owned directly which were contributed to The Tassos Gianakakos 2020 Annuity Trust on May 1, 2020.
Includes 6,000 shares previously owned directly which were contributed to The TKG 2020 Irrevocable Trust on May 1, 2020.
/s/ Cynthia J. Ladd, as Attorney-in-Fact
2020-05-06